Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |